ESMO 2019 IMpassion130 Update on Unresectable Locally Advanced / Metastatic TNBC: SP142 PD-L1+ Patients Derived the Greatest Clinical Benefit w/ Atezolizumab+nab-Paclitaxel

January 7, 2020

1 Comment
Login to view comments. Click here to Login